Cell & Gene
Japan Launches Elevidys Gene Therapy For Young Children With Duchenne Muscular Dystrophy
- Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years - Company is eligible ...
February 27, 2026 | News
Astellas And Vir Biotechnology Forge Global Partnership To Advance VIR 5500 In Prostate Cancer
- Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues - - Astellas to lead commerci...
February 25, 2026 | News
iRegene Advances Global Cell Therapy Programme With Key Parkinson’s And MSA Clinical Milestones
The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical...
February 25, 2026 | News
CARsgen Therapeutics Advances Commercial CAR T Cell Manufacturing With Shanghai Strategic Partnership
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that through its in...
February 17, 2026 | News
Sky Labs Launches CART ON Ring Based Ward Blood Pressure Monitoring System
Establishment of a blood pressure monitoring lineup that addresses every environment, from daily life to hospital wards Sky Labs (CEO Jack Byunghwan Lee) ...
February 12, 2026 | News
CaseBioscience Launches Cell Therapy Grade Cryopreservation And Hypothermic Storage Solutions At Advanced Therapies Week 2026
Introducing cell therapy–grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performa...
February 10, 2026 | News
AstraZeneca Commits $15 Billion Investment To Expand R&D And Manufacturing Footprint In China Through 2030
Landmark investment will expand AstraZeneca’s capabilities to discover, develop, and manufacture transformative new treatments in China In...
February 03, 2026 | News
Simcere Pharmaceutical Group Licenses First In Class TL1A IL23p19 Bispecific Antibody To Boehringer Ingelheim For Inflammatory Bowel Disease
Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. Lice...
January 29, 2026 | News
Novo Nordisk Secures US FDA Approval For Once Daily Oral GLP 1 Weight Management Pill
The US Food and Drug Administration (FDA) has approved Novo Nordisk's new once-daily pill for weight management, designed to help people reduce excess body...
January 29, 2026 | News
AstraZeneca Acquires Full Global Rights To CCAR031 From AbelZeta Pharma
AbelZeta Pharma, Inc. ("AbelZeta"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietar...
January 20, 2026 | News
Immunofoco CAR T Therapy IMC002 Posts Strong Responses In Advanced Gastric And Gej Cancers At Asco Gi 2026
Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from ...
January 15, 2026 | News
Management of Relapsed/Refractory Multiple Myeloma
Doctors and researchers have made huge steps in treating this blood cancer lately. Yet, most people face a time when the cancer returns or stops responding...
January 14, 2026 | News
Oricell Raises 70M$ In Series C1 To Advance First In Class CAR T Therapy For Liver Cancer
Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced the closing of a $70M Ser...
January 14, 2026 | News
FDA Signals A Faster Regulatory Path For Cell And Gene Therapies
The U.S. Food and Drug Administration announced it is sharing information about the agency’s flexible appro...
January 13, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
